FMR LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SHS USD ASND | FMR LLC | 3,852,101 6.600% | -794,842 (-17.10%) | Filing |